Evidence map›Paper›PMID 21520334›Full record

ArticleHuman mutation2011

Novel polymorphic AluYb8 insertion in the WNK1 gene is associated with blood pressure variation in Europeans.

Margus Putku, Katrin Kepp, Elin Org, Siim Sõber, David Comas, Margus Viigimaa, Gudrun Veldre, Peeter Juhanson, Pille Hallast, Neeme Tõnisson and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Human mutation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. The CUL3/KLHL3-WNK-SPAK/OSR1 pathway as a target for antihypertensive therapy.American journal of physiology. Renal physiology · 2016
    Article
  8. Does Renal Denervation Fit All Resistant Hypertension? The Role of Genetics.Journal of clinical hypertension (Greenwich, Conn.) · 2016
    Article
  9. Article
  10. Lack of family-based association between common variations in WNK1 and blood pressure level.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 5 countries.

Margus PutkuHuman Molecular Genetics Research Group, Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia.
Katrin Kepp
Elin Org
Siim Sõber
David Comas
Margus Viigimaa
Gudrun Veldre
Peeter Juhanson
Pille Hallast
Neeme Tõnisson
HYPertension in ESTonia (HYPEST)
Sue Shaw-Hawkins
Mark J Caulfield
BRItish Genetics of HyperTension (BRIGHT)
Elza Khusnutdinova
Viktor Kožich
Patricia B Munroe
Maris Laan
University of Tartu · EEQueen Mary University of London · GBCharles University · CZRussian Academy of Sciences · RUTallinn University of Technology · EEUniversitat Pompeu Fabra · ES

Funding

British Heart Foundation PG02/128Howard Hughes Medical Institute 55005617Medical Research Council G9521010Medical Research Council G9521010DWellcome Trust 070191/Z/03/ZWellcome Trust 070255/Z/03/ZWellcome Trust 090532
6 · The paper itself

Abstract

Mutations in WNK1 and WNK4 cause familial hypertension, the Gordon syndrome. WNK1 and WNK4 conserved noncoding regions were targeted to polymorphism screening using DHPLC and DGGE. The scan identified an undescribed polymorphic AluYb8 insertion in WNK1 intron 10. Screening in primates revealed that this Alu-insertion has probably occurred in human lineage. Genotyping in 18 populations from Europe, Asia, and Africa (n = 854) indicated an expansion of the WNK1 AluYb8 bearing chromosomes out of Africa. The allele frequency in Sub-Saharan Africa was ~3.3 times lower than in other populations (4.8 vs. 15.8%; P = 9.7 × 10(-9) ). Meta-analysis across three European sample sets (n = 3,494; HYPEST, Estonians; BRIGHT, the British; CADCZ, Czech) detected significant association of the WNK1 AluYb8 insertion with blood pressure (BP; systolic BP, P = 4.03 × 10(-3) , effect 1.12; diastolic BP, P = 1.21 × 10(-2) , effect 0.67). Gender-stratified analysis revealed that this effect might be female-specific (n = 2,088; SBP, P = 1.99 × 10(-3) , effect 1.59; DBP P = 3.64 × 10(-4) , effect 1.23; resistant to Bonferroni correction), whereas no statistical support was identified for the association with male BP (n = 1,406). In leucocytes, the expressional proportions of the full-length WNK1 transcript and the splice-form skipping exon 11 were significantly shifted in AluYb8 carriers compared to noncarriers. The WNK1 AluYb8 insertion might affect human BP via altering the profile of alternatively spliced transcripts.

Indexed as

AdultAfricaAgedAlternative SplicingAlu ElementsArthrogryposisAsiaBlood PressureCleft PalateClubfootEuropeExonsFemaleGenetic VariationHand Deformities, CongenitalHumansIntracellular Signaling Peptides and ProteinsMinor Histocompatibility AntigensProtein Serine-Threonine KinasesWNK1 protein, humanWNK Lysine-Deficient Protein Kinase 1

Identifiers

PMID21520334
PMCPMC3298642
OpenAlexW2101585109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.